| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 15 May 2024 | 8 May 2024 |
| SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Meeting of the Board of Directors of SeQuent Scientific Limited is scheduled to be held on Wednesday May 15 2024 inter alia to: 1. Consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2024. 2. Consider dividend for the year ended March 31 2024 if any. Audited standalone and Consolidated Financial Results for the quarter and Year ended March 31, 2024. The Board has not recommended any dividend for F.Y. 2023-24. Audited standalone and Consolidated Financial Results for the quarter and Year ended March 31, 2024 1. Audited Consolidated Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2024 with an unmodified opinion. 2. Audited Standalone Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2024 with an unmodified opinion. 3. The Board has not recommended any dividend for F.Y. 2023-24. (As Per BSE Announcement Dated on: 15/05/2024) | ||
| Board Meeting | 13 Feb 2024 | 6 Feb 2024 |
| SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2023. Financial results for quarter ended December 31 2023 Appointment of Company Secretary and Compliance Officer (As Per BSE Announcement dated on 13.02.2024) | ||
| Board Meeting | 5 Feb 2024 | 5 Feb 2024 |
| Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the following: 1. Notice of Postal Ballot for seeking Members approval, a) To create security on the undertakings of the Company under Section 180(1)(a) of the Companies Act, 2013 and, b) To consider and approve the divestment by the Company of its shareholding and beneficial interest in material subsidiary of the Company and to approve sale, disposal, and lease of assets exceeding 20% of the assets of the material subsidiaries of the Company pursuant to the provisions of Regulation 24(5) & 24(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Re-submission of outcome dated February 05, 2024 (As Per BSE Announcement Dated on 22/05/2024) | ||
| Board Meeting | 6 Nov 2023 | 30 Oct 2023 |
| SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Meeting of the Board of Directors of SeQuent Scientific Limited is scheduled to be held on Monday November 06 2023 to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30 2023. Disclosure of unaudited consolidated and standalone financial results for quarter and half year ended September 30, 2023 Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2023. In this regard, kindly find enclosed the following: 1. Unaudited Consolidated Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2023. 2. Unaudited Standalone Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2023. The Board Meeting commenced at 08:15 p.m. and concluded at 09:55 p.m. Appointment of Mr. Saurav Bhala as Chief Financial Officer of the Company (As Per BSE Announcement Dated on 06.11.2023) | ||
| Board Meeting | 14 Sep 2023 | 14 Sep 2023 |
| Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the following: 1. Sale/Transfer of the Companys API facility situated at Tarapur, Boisar Dist. Thane, Maharashtra - 401506, India. Disclosure as required under Regulation 30 of SEBI LODR read with Schedule III, Part A, A.1 will be provided when a binding agreement is entered into for the proposed sale. 2. Appointment of M/s. Grant Thornton Bharat LLP, Chartered Accountants as Internal Auditors of the Company.3. Notice of Postal Ballot for seeking Members approval for Sale/Transfer of the Companys API facility situated at Tarapur, Boisar Dist. Thane, Maharashtra - 401506, India. Outcome of Board Meeting held on September 14, 2023 | ||
| Board Meeting | 10 Aug 2023 | 4 Aug 2023 |
| SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Meeting of the Board of Directors of SeQuent Scientific Limited is scheduled to be held on Thursday August 10 2023 to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30 2023. Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023. In this regard, kindly find enclosed the following: 1. Unaudited Consolidated Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter ended June 30, 2023. 2. Unaudited Standalone Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter ended June 30, 2023. The Board Meeting commenced at 08:15 p.m. and concluded at 10:00 p.m. (As per BSE Announcement Dated on 10/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
